Abstract
The plasma levels of homovanillic and vanillylmandelic acids were determined in 84 children with neuroblastoma prior to treatment to evaluate the usefulness of these parameters for the diagnosis of this disease. Elevated levels of one or both of these metabolites were observed in 50% of children with Stage I or II disease, in 88% of those with Stage III, in 93% of those with Stage IV and in 100% of children with Stage IV-S for a total of 88% of all patients. The clinical course of the disease can be followed readily by determination of these metabolites, successful therapy or surgery being accompanied by a corresponding decrease in the plasma levels and relapse by a corresponding increase. Determination of homovanillic and vanillylmandelic acids in plasma can obviate many of the problems associated with the collection of urine, especially in young children or ambulant patients, and thus facilitates a more frequent control with consequent advantages for the management of this disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- HVA:
-
Homovanillic acid
- VMA:
-
Vanillylmandelic acid
References
Alvarado CS, Camp VM, Faraj BA, Bain RP, Kim TH, Ragab AH (1985) Plasma dopa and catecholamines in the diagnosis and follow-up of children with neuroblastoma. Am J Pediatr Hematol Oncol 7:221–227
Evans AE, D'Angio GJ, Randolph JG (1971) A proposed staging for children with neuroblastoma. Cancer 27:374–378
Gitlow SE, Mendlowitz M, Wilk EK, Wilk S, Wolf RL, Bertani LM (1968) Excretion of catecholamine catabolites by normal children. J Lab Clin Med 72:612–620
Hnneman DH (1983) Mass fragmentographic determination of homovanillic and 4-hydroxy-3-methoxy mandelic acids in 50 μl plasma. Clin Chim Acta 135:169–174
Hunneman DH, Jonas W, Gabriel M, Gahr M (1986) Effect of age on homovanillic and 4-hydroxy-3-methoxymandelic acid levels in plasma. Eur J Pediatr 145:555–557
Käser H (1966) Catecholamine-producing neural tumours other than pheochromocytoma. Pharmacol Rev 18:659–665
Krivit W, Mirkin BL, Freier E, Nesbit M, Cooper MJ (1980) Serum catecholamine metabolites in stage IV neuroblastoma. In: Evans AE (ed) Advances in neuroblastoma research. Raven Press, New York, pp 33–42
LaBrosse J, Com-Nougue C, Zucker J, Comoy E, Bohuon C, Lemerle J, Schweisguth O (1980) Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumours. Cancer Res 40:1995–2001
Laug WE, Siegel SE, Shaw KNF, Landing B, Baptista J, Gutenstein M (1978) Initial urinary catecholamine metabolites concentrations and prognosis in neuroblastoma. Pediatrics 62:77–83
Pisano JJ, Crout JR, Abraham D (1962) Determination of 3-methoxy-4-hydroxymandelic acid in urine. Clin Chim Acta 7: 285–291
Vollrath M, Altmannsberger M, Hunneman DH, Goebel HH, Osborn M (1984) Esthesioneuroblastoma: ultrastructural, immunohistological and biochemical investigation of one case. Arch Otorhinolaryngol 239:133–144
Voorhees ML, Gardner LI (1962) The value of serial catecholamine determinations in children with neuroblastoma. Pediatrics 30:241–246
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gahr, M., Hunneman, D.H. The value of determination of homovanillic and vanillylmandelic acids in plasma for the diagnosis and follow-up of neuroblastoma in children. Eur J Pediatr 146, 489–493 (1987). https://doi.org/10.1007/BF00441600
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00441600